| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 261 | 58.352 | 123.142 | 287.336 | 299.706 | 204.367 | 249.285 | 249.596 | 271.211 | 296.823 |
| Total Income - EUR | 261 | 58.352 | 123.142 | 287.942 | 301.814 | 269.970 | 249.286 | 249.598 | 272.172 | 297.080 |
| Total Expenses - EUR | 260 | 41.372 | 97.446 | 252.005 | 293.205 | 196.703 | 242.276 | 242.183 | 210.708 | 284.125 |
| Gross Profit/Loss - EUR | 1 | 16.980 | 25.696 | 35.936 | 8.609 | 73.267 | 7.010 | 7.415 | 61.464 | 12.955 |
| Net Profit/Loss - EUR | -7 | 16.396 | 24.465 | 33.057 | 5.590 | 70.690 | 4.773 | 4.969 | 59.069 | 8.201 |
| Employees | 1 | 4 | 4 | 3 | 5 | 4 | 4 | 4 | 5 | 5 |
Check the financial reports for the company - Cels Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 247 | 29.546 | 52.502 | 73.975 | 117.542 | 129.529 | 97.356 | 82.553 | 104.913 | 130.080 |
| Current Assets | 360 | 7.508 | 19.566 | 28.134 | 19.619 | 71.736 | 69.446 | 57.242 | 99.248 | 63.019 |
| Inventories | 54 | 0 | 317 | 0 | 0 | 0 | 0 | 6.428 | 0 | 2.085 |
| Receivables | 261 | 6.855 | 12.819 | 27.066 | 19.453 | 62.031 | 44.389 | 50.522 | 82.091 | 35.962 |
| Cash | 45 | 654 | 6.430 | 1.068 | 167 | 9.705 | 25.057 | 291 | 17.157 | 24.972 |
| Shareholders Funds | 38 | 16.456 | 40.642 | 72.953 | 77.131 | 146.359 | 91.347 | 9.830 | 68.869 | -47.953 |
| Social Capital | 45 | 67 | 66 | 64 | 63 | 62 | 61 | 61 | 61 | 60 |
| Debts | 570 | 20.599 | 31.426 | 29.156 | 60.031 | 54.906 | 75.455 | 129.965 | 135.292 | 273.459 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 37.660 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Cels Med S.r.l.